These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8337368)

  • 1. Myocardial perfusion imaging using technetium-99m radiopharmaceuticals.
    Kiat H; Berman DS; Maddahi J
    Radiol Clin North Am; 1993 Jul; 31(4):795-815. PubMed ID: 8337368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear cardiology, Part III: Scintigraphic evaluation of cardiac perfusion.
    Everaert H; Maes A; Hambye AS; Mesotten L; Mortelmans L; Franken PR
    J Nucl Med Technol; 1998 Sep; 26(3):164-9; quiz 172-3. PubMed ID: 9755435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [99mTc-Cardiolite and Tl-201 in the evaluation of myocardial blood flow. Comparison of their diagnostic usefulness].
    Gosiewska-Marcinkowska E
    Kardiol Pol; 1992; 36(1):18-23. PubMed ID: 1533887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different tracers and stressors in patients with coronary artery disease: how to standardize clinical questions and nuclear cardiology answers.
    Marzullo P; Sambuceti G; Gimelli A; Giorgetti A; Parodi O
    J Nucl Biol Med (1991); 1994 Dec; 38(4):566-72. PubMed ID: 7786918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between thallium-201, technetium-99m-sestamibi and technetium-99m-teboroxime planar myocardial perfusion imaging in detection of coronary artery disease.
    Taillefer R; Lambert R; Essiambre R; Phaneuf DC; Léveillé J
    J Nucl Med; 1992 Jun; 33(6):1091-8. PubMed ID: 1534575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newer technetium-99m--labeled myocardial perfusion imaging agents: clinical indications.
    Bisson G; Hendel RC; Taillefer R
    Am J Card Imaging; 1994 Jul; 8(3):213-22. PubMed ID: 7950172
    [No Abstract]   [Full Text] [Related]  

  • 7. Tracer selection with different stress modalities based on tracer kinetics.
    Heller GV
    J Nucl Cardiol; 1996; 3(6 Pt 2):S15-21. PubMed ID: 8989682
    [No Abstract]   [Full Text] [Related]  

  • 8. New agents labelled with technetium 99m for myocardial perfusion imaging.
    Taillefer R
    Can Assoc Radiol J; 1992 Aug; 43(4):258-66. PubMed ID: 1386280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-labeled myocardial perfusion agents.
    Heo J; Iskandrian AS
    Cardiol Clin; 1994 May; 12(2):187-98. PubMed ID: 8033172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Tc-99m sestamibi perfusion imaging and echocardiography using an arbutamine infusion for the detection of coronary artery disease.
    Hendel RC; Kostuk W; Beanlands RS; Chaudry F; Ascah KJ; Young H; Ruddy TD
    Am J Cardiol; 1997 Jun; 79(11):1518-21. PubMed ID: 9185645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of myocardial blood flow by radiolabeled tracers.
    Wilson RA
    J Nucl Med; 1993 Sep; 34(9):1518-9. PubMed ID: 8355073
    [No Abstract]   [Full Text] [Related]  

  • 12. Advances in myocardial perfusion imaging: 99mTc-teboroxime.
    Pieri PL; Strauss HW
    J Nucl Biol Med (1991); 1992; 36(2 Suppl):22-8. PubMed ID: 1450239
    [No Abstract]   [Full Text] [Related]  

  • 13. Technetium-labeled myocardial imaging agents.
    Iskandrian AS; Heo J
    Int J Card Imaging; 1992; 8(4):277-87. PubMed ID: 1464728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ECG-gated and static technetium-99m-SESTAMIBI planar myocardial perfusion imaging: a comparison with thallium-201 and study of observer variabilities.
    Verzijlbergen JF; Cramer MJ; Niemeyer MG; Ascoop CA; Van der Wall EE; Pauwels EK
    Am J Physiol Imaging; 1990; 5(2):60-7. PubMed ID: 2147553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfusion imaging in ischemic heart disease.
    Rivitz SM; Deluca SA
    Am Fam Physician; 1993 Nov; 48(6):1071-8. PubMed ID: 8237730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA approves two new technetium-labeled cardiac agents and a pharmacologic alternative to exercise in stress-thallium studies.
    Ghosh PR
    J Nucl Med; 1991 May; 32(5):11N, 14N-16N, 19N. PubMed ID: 1827149
    [No Abstract]   [Full Text] [Related]  

  • 17. [Myocardial scintigraphy with Tc-99m-MIBI for assessing the extent and severity of coronary disease: a comparison with thallium-201 and equilibrium angiocardioscintigraphy].
    Leoncini M; Sciagrà R; Bisi G; Santoro GM; Fazzini PF
    G Ital Cardiol; 1993 Feb; 23(2):127-38. PubMed ID: 8491353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thallium-201 and sestamibi: principles and kinetics of the two tracers].
    Parodi O
    G Ital Cardiol; 1991 Aug; 21(8):885-8. PubMed ID: 1837528
    [No Abstract]   [Full Text] [Related]  

  • 19. Perfusion scintigraphy and evaluation of myocardial viability.
    McKillop JH
    Nucl Med Commun; 1991 Aug; 12(8):659-62. PubMed ID: 1780107
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of coronary occlusion and myocardial viability on myocardial activity of technetium-99m-sestamibi.
    Freeman I; Grunwald AM; Hoory S; Bodenheimer MM
    J Nucl Med; 1991 Feb; 32(2):292-8. PubMed ID: 1825111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.